The Huffington Post – We know that fasting can be great for the body. Preliminary research shows it could also do your brain good ― especially if you’re at risk for neurodegenerative disorders like Alzheimer’s and Parkinson’s.
The Conversation – The FDA approved a Phase III clinical trial to confirm the effectiveness of treating post-traumatic stress disorder with MDMA. However, the media have largely been referring to Ecstasy – the street name for this drug – as the treatment.
Nature – US president-elect Donald Trump has chosen people for key jobs overseeing national security, defence and environmental policy. But he has not addressed whether he will fill the most important job in US science: presidential science adviser.
ABC News – With a DNA profile but no suspect to match in the strangling of a woman who went for a run and met a killer, authorities are looking to an emerging approach: using the DNA to look for the killer's relatives.
Sean Harrold holds degrees in biology and philosophy and is a graduate student in the Duke Initiative for Science & Society’s Masters of Bioethics & Science Policy Program.In the following interview Sean shares how his background in biology led him to the Masters in Bioethics and Science Policy Program at Duke and reflects on his experience working with a cutting-edge bioetech company.
Department of Health and Human Services – Today, Health and Human Services announced nearly $39 million in funding to 23 health centers in Puerto Rico, American Samoa and the U.S. Virgin Islands and $1 million to two Primary Care Associations (PCAs) to help combat the Zika virus.
Science Magazine – There have been few happy endings when it comes to spinal muscular atrophy (SMA), the most common genetic cause of death in childhood. But an innovative drug that helps cells bypass the genetic flaw responsible for SMA may be approved as soon as this month.